[Role of platelet-activating factor in progesterone synthesis and vascular endothelial growth factor expression in rat luteal cells]

Sheng Li Xue Bao. 2008 Apr 25;60(2):275-8.
[Article in Chinese]

Abstract

The present study aimed to investigate the role of platelet-activating factor (PAF) in progesterone synthesis and vascular endothelial growth factor (VEGF) expression in rat luteal cells. Immature (25-28 days old) female Sprague-Dawley rats were injected subcutaneously with 50 IU pregnant mare serum gonadotrophin (PMSG), and 25 IU human chorionic gonadotrophin (hCG) 48 h later, to induce follicular development and luteum formation. On day 6 after hCG administration (the day of hCG administration was the first day), the rats were killed by guillotine and the ovarian luteal cells were collected. After incubation for 24 h, luteal cells were incubated without or with different doses (0.1 μg/mL, 1 μg/mL, 10 μg/mL) of PAF at 37 °C (5% CO(2)) for 24 h, and then progesterone concentration was evaluated by radioimmunoassay (RIA); apoptotic rate and VEGF mRNA expression in luteal cells were assessed by flow cytometry and RT-PCR, respectively. The results showed that PAF promoted progesterone production, with a maximal effect at 1 μg/mL (P<0.05); PAF increased apoptotic rate but not in a dose-dependent manner, and 10 μg/mL PAF enhanced apoptotic rate significantly (P<0.05); furthermore, PAF stimulated VEGF mRNA expression in luteal cells, especially at 1 μg/mL (P<0.01). It is suggested that PAF regulates progesterone synthesis and VEGF mRNA expression in luteal cells to mediate corpus luteum formation in rat ovary.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chorionic Gonadotropin / pharmacology
  • Corpus Luteum / drug effects
  • Female
  • Luteal Cells / drug effects
  • Luteal Cells / metabolism*
  • Platelet Activating Factor / pharmacology*
  • Pregnancy
  • Progesterone / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Chorionic Gonadotropin
  • Platelet Activating Factor
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Progesterone